Header Logo

Connection

Kenneth Rock to Antigen-Presenting Cells

This is a "connection" page, showing publications Kenneth Rock has written about Antigen-Presenting Cells.
Connection Strength

3.394
  1. Hernandez MG, Shen L, Rock KL. CD40 on APCs is needed for optimal programming, maintenance, and recall of CD8+ T cell memory even in the absence of CD4+ T cell help. J Immunol. 2008 Apr 01; 180(7):4382-90.
    View in: PubMed
    Score: 0.284
  2. Shen L, Rock KL. Priming of T cells by exogenous antigen cross-presented on MHC class I molecules. Curr Opin Immunol. 2006 Feb; 18(1):85-91.
    View in: PubMed
    Score: 0.241
  3. Sigal LJ, Rock KL. Bone marrow-derived antigen-presenting cells are required for the generation of cytotoxic T lymphocyte responses to viruses and use transporter associated with antigen presentation (TAP)-dependent and -independent pathways of antigen presentation. J Exp Med. 2000 Oct 16; 192(8):1143-50.
    View in: PubMed
    Score: 0.169
  4. Colbert JD, Cruz FM, Rock KL. Cross-presentation of exogenous antigens on MHC I molecules. Curr Opin Immunol. 2020 06; 64:1-8.
    View in: PubMed
    Score: 0.160
  5. Sigal LJ, Crotty S, Andino R, Rock KL. Cytotoxic T-cell immunity to virus-infected non-haematopoietic cells requires presentation of exogenous antigen. Nature. 1999 Mar 04; 398(6722):77-80.
    View in: PubMed
    Score: 0.151
  6. Vidard L, Kovacsovics-Bankowski M, Kraeft SK, Chen LB, Benacerraf B, Rock KL. Analysis of MHC class II presentation of particulate antigens of B lymphocytes. J Immunol. 1996 Apr 15; 156(8):2809-18.
    View in: PubMed
    Score: 0.124
  7. Kovacsovics-Bankowski M, Rock KL. Presentation of exogenous antigens by macrophages: analysis of major histocompatibility complex class I and II presentation and regulation by cytokines. Eur J Immunol. 1994 Oct; 24(10):2421-8.
    View in: PubMed
    Score: 0.111
  8. Michalek MT, Grant EP, Gramm C, Goldberg AL, Rock KL. A role for the ubiquitin-dependent proteolytic pathway in MHC class I-restricted antigen presentation. Nature. 1993 Jun 10; 363(6429):552-4.
    View in: PubMed
    Score: 0.102
  9. Kovacsovics-Bankowski M, Clark K, Benacerraf B, Rock KL. Efficient major histocompatibility complex class I presentation of exogenous antigen upon phagocytosis by macrophages. Proc Natl Acad Sci U S A. 1993 Jun 01; 90(11):4942-6.
    View in: PubMed
    Score: 0.101
  10. Dang LH, Lien LL, Benacerraf B, Rock KL. A mutant antigen-presenting cell defective in antigen presentation expresses class II MHC molecules with an altered conformation. J Immunol. 1993 May 15; 150(10):4206-17.
    View in: PubMed
    Score: 0.101
  11. Rock KL, Rothstein L, Gamble S, Fleischacker C. Characterization of antigen-presenting cells that present exogenous antigens in association with class I MHC molecules. J Immunol. 1993 Jan 15; 150(2):438-46.
    View in: PubMed
    Score: 0.099
  12. Rock KL, Rothstein L, Benacerraf B. Analysis of the association of peptides of optimal length to class I molecules on the surface of cells. Proc Natl Acad Sci U S A. 1992 Oct 01; 89(19):8918-22.
    View in: PubMed
    Score: 0.097
  13. Goldberg AL, Rock KL. Proteolysis, proteasomes and antigen presentation. Nature. 1992 Jun 04; 357(6377):375-9.
    View in: PubMed
    Score: 0.095
  14. Rock KL, Rothstein L, Fleischacker C, Gamble S. Inhibition of class I and class II MHC-restricted antigen presentation by cytotoxic T lymphocytes specific for an exogenous antigen. J Immunol. 1992 May 15; 148(10):3028-33.
    View in: PubMed
    Score: 0.094
  15. Michalek MT, Benacerraf B, Rock KL. The class II MHC-restricted presentation of endogenously synthesized ovalbumin displays clonal variation, requires endosomal/lysosomal processing, and is up-regulated by heat shock. J Immunol. 1992 Feb 15; 148(4):1016-24.
    View in: PubMed
    Score: 0.093
  16. Grant EP, Rock KL. MHC class I-restricted presentation of exogenous antigen by thymic antigen-presenting cells in vitro and in vivo. J Immunol. 1992 Jan 01; 148(1):13-8.
    View in: PubMed
    Score: 0.092
  17. Michalek MT, Benacerraf B, Rock KL. Weak base amines can inhibit class I MHC-restricted antigen presentation. J Immunol. 1991 Jan 15; 146(2):449-56.
    View in: PubMed
    Score: 0.086
  18. Rock KL, Gamble S, Rothstein L. Presentation of exogenous antigen with class I major histocompatibility complex molecules. Science. 1990 Aug 24; 249(4971):918-21.
    View in: PubMed
    Score: 0.084
  19. Dang LH, Michalek MT, Takei F, Benaceraff B, Rock KL. Role of ICAM-1 in antigen presentation demonstrated by ICAM-1 defective mutants. J Immunol. 1990 Jun 01; 144(11):4082-91.
    View in: PubMed
    Score: 0.082
  20. Michalek MT, Benacerraf B, Rock KL. Two genetically identical antigen-presenting cell clones display heterogeneity in antigen processing. Proc Natl Acad Sci U S A. 1989 May; 86(9):3316-20.
    View in: PubMed
    Score: 0.076
  21. Falo LD, Benacerraf B, Rothstein L, Rock KL. Cerulenin is a potent inhibitor of antigen processing by antigen-presenting cells. J Immunol. 1987 Dec 15; 139(12):3918-23.
    View in: PubMed
    Score: 0.069
  22. Falo LD, Haber SI, Herrmann S, Benacerraf B, Rock KL. Characterization of antigen association with accessory cells: specific removal of processed antigens from the cell surface by phospholipases. Proc Natl Acad Sci U S A. 1987 Jan; 84(2):522-6.
    View in: PubMed
    Score: 0.065
  23. Rock KL, Haber SI, Liano D, Benacerraf B, Abbas AK. Antigen presentation by hapten-specific B lymphocytes. III. Analysis of the immunoglobulin-dependent pathway of antigen presentation to interleukin 1-dependent T lymphocytes. Eur J Immunol. 1986 Nov; 16(11):1407-12.
    View in: PubMed
    Score: 0.064
  24. Falo LD, Benacerraf B, Rock KL. Phospholipase treatment of accessory cells that have been exposed to antigen selectively inhibits antigen-specific Ia-restricted, but not allospecific, stimulation of T lymphocytes. Proc Natl Acad Sci U S A. 1986 Sep; 83(18):6994-7.
    View in: PubMed
    Score: 0.064
  25. Shi Y, Galusha SA, Rock KL. Cutting edge: elimination of an endogenous adjuvant reduces the activation of CD8 T lymphocytes to transplanted cells and in an autoimmune diabetes model. J Immunol. 2006 Apr 01; 176(7):3905-8.
    View in: PubMed
    Score: 0.062
  26. Falo LD, Sullivan K, Benacerraf B, Mescher MF, Rock KL. Analysis of antigen presentation by metabolically inactive accessory cells and their isolated membranes. Proc Natl Acad Sci U S A. 1985 Oct; 82(19):6647-51.
    View in: PubMed
    Score: 0.060
  27. Rock KL, Shen L. Cross-presentation: underlying mechanisms and role in immune surveillance. Immunol Rev. 2005 Oct; 207:166-83.
    View in: PubMed
    Score: 0.060
  28. Abbas AK, Haber S, Rock KL. Antigen presentation by hapten-specific B lymphocytes. II. Specificity and properties of antigen-presenting B lymphocytes, and function of immunoglobulin receptors. J Immunol. 1985 Sep; 135(3):1661-7.
    View in: PubMed
    Score: 0.059
  29. Rock KL, Benacerraf B. Inhibition of antigen-specific T lymphocyte activation by structurally related Ir gene-controlled polymers. II. Competitive inhibition of I-E-restricted, antigen-specific T cell responses. J Exp Med. 1984 Dec 01; 160(6):1864-79.
    View in: PubMed
    Score: 0.056
  30. Rock KL, Benacerraf B, Abbas AK. Antigen presentation by hapten-specific B lymphocytes. I. Role of surface immunoglobulin receptors. J Exp Med. 1984 Oct 01; 160(4):1102-13.
    View in: PubMed
    Score: 0.056
  31. Shi Y, Rock KL. Cell death releases endogenous adjuvants that selectively enhance immune surveillance of particulate antigens. Eur J Immunol. 2002 01; 32(1):155-62.
    View in: PubMed
    Score: 0.046
  32. Sigal LJ, Reiser H, Rock KL. The role of B7-1 and B7-2 costimulation for the generation of CTL responses in vivo. J Immunol. 1998 Sep 15; 161(6):2740-5.
    View in: PubMed
    Score: 0.037
  33. Rock KL, Fleischacker C, Gamble S. Peptide-priming of cytolytic T cell immunity in vivo using beta 2-microglobulin as an adjuvant. J Immunol. 1993 Feb 15; 150(4):1244-52.
    View in: PubMed
    Score: 0.025
  34. Vidard L, Rock KL, Benacerraf B. Heterogeneity in antigen processing by different types of antigen-presenting cells. Effect of cell culture on antigen processing ability. J Immunol. 1992 Sep 15; 149(6):1905-11.
    View in: PubMed
    Score: 0.024
  35. Falo LD, Colarusso LJ, Benacerraf B, Rock KL. Serum proteases alter the antigenicity of peptides presented by class I major histocompatibility complex molecules. Proc Natl Acad Sci U S A. 1992 Sep 01; 89(17):8347-50.
    View in: PubMed
    Score: 0.024
  36. Vidard L, Rock KL, Couderc J, Mouton D, Benacerral B. Processing and presentation of ovalbumin in mice genetically selected for antibody response. Eur J Immunol. 1992 Aug; 22(8):2165-8.
    View in: PubMed
    Score: 0.024
  37. Rock KL, Rothstein L, Gamble S, Gramm C, Benacerraf B. Chemical cross-linking of class I molecules on cells creates receptive peptide binding sites. J Immunol. 1992 Mar 01; 148(5):1451-7.
    View in: PubMed
    Score: 0.023
  38. Vidard L, Rock KL, Benacerraf B. The generation of immunogenic peptides can be selectively increased or decreased by proteolytic enzyme inhibitors. J Immunol. 1991 Sep 15; 147(6):1786-91.
    View in: PubMed
    Score: 0.023
  39. Rock KL, Gamble S, Rothstein L, Benacerraf B. Reassociation with beta 2-microglobulin is necessary for Db class I major histocompatibility complex binding of an exogenous influenza peptide. Proc Natl Acad Sci U S A. 1991 Jan 01; 88(1):301-4.
    View in: PubMed
    Score: 0.021
  40. Rock KL, Rothstein LE, Gamble SR, Benacerraf B. Reassociation with beta 2-microglobulin is necessary for Kb class I major histocompatibility complex binding of exogenous peptides. Proc Natl Acad Sci U S A. 1990 Oct; 87(19):7517-21.
    View in: PubMed
    Score: 0.021
  41. Benacerraf B, Michalek MT, Dang LH, Rock KL. The importance of antigen processing in determinant selection and of the cell membrane as a reservoir of processed antigen. Cold Spring Harb Symp Quant Biol. 1989; 54 Pt 1:293-8.
    View in: PubMed
    Score: 0.019
  42. Rock KL, Yeh ET, Gramm CF, Haber SI, Reiser H, Benacerraf B. TAP, a novel T cell-activating protein involved in the stimulation of MHC-restricted T lymphocytes. J Exp Med. 1986 Feb 01; 163(2):315-33.
    View in: PubMed
    Score: 0.015
  43. Rock KL, Yeh ET, Benacerraf B. Selection of thymocyte MHC restriction specificity in vitro. J Mol Cell Immunol. 1984; 1(5):311-20.
    View in: PubMed
    Score: 0.013
  44. Mazzaccaro RJ, Gedde M, Jensen ER, van Santen HM, Ploegh HL, Rock KL, Bloom BR. Major histocompatibility class I presentation of soluble antigen facilitated by Mycobacterium tuberculosis infection. Proc Natl Acad Sci U S A. 1996 Oct 15; 93(21):11786-91.
    View in: PubMed
    Score: 0.008
  45. Van Kaer L, Ashton-Rickardt PG, Eichelberger M, Gaczynska M, Nagashima K, Rock KL, Goldberg AL, Doherty PC, Tonegawa S. Altered peptidase and viral-specific T cell response in LMP2 mutant mice. Immunity. 1994 Oct; 1(7):533-41.
    View in: PubMed
    Score: 0.007
  46. Vidard L, Rock KL, Benacerraf B. Diversity in MHC class II ovalbumin T cell epitopes generated by distinct proteases. J Immunol. 1992 Jul 15; 149(2):498-504.
    View in: PubMed
    Score: 0.006
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.